Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy - Yahoo Finance

Submitted by Anonymous (not verified) on Thu, 04/07/2022 - 11:00

Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy  Yahoo Finance